CyBio AG operates in the Electromedical equipment sector. CyBio AG is a Germany-based company, providing the development, manufacture and marketing of laboratory systems and equipment, as well as related software. The Company offers systems for the preparation, transport of specified substances, as well as systems for the detection of pharmaceutical and biotechnological agents in those substances. Its core products are simultaneous pipetting and imaging technologies. The Company operates through five subsidiaries, including CyBio Central Europe GmbH, CLS Laborautomationssysteme GmbH i. L. Reutlingen (in liquidation), CyBio US Inc, CyBio Northern Europe Ltd and CyBio Japan Co, Ltd. (in liquidation). Its customers are pharmaceutical and biotechnological companies in the European Union and the United States, as well as academic research institutes. In
our complete report available for purchase the company is compared to: M-U-T Ag, SFC Energy AG and Sedlbauer AG.